Matches in Nanopublications for { ?s ?p "[In primary samples, MIR129-2 methylation was absent in AML and CML, but detected in 5% ALL, 45.9% CLL, 49.5% MM at diagnosis, and 59.1% NHL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP993309.RAA0Xa1FoQ3vKva7sXUDSjWCoUxp6Uxa_u5x_Ha_DKAqY130_assertion description "[In primary samples, MIR129-2 methylation was absent in AML and CML, but detected in 5% ALL, 45.9% CLL, 49.5% MM at diagnosis, and 59.1% NHL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP993309.RAA0Xa1FoQ3vKva7sXUDSjWCoUxp6Uxa_u5x_Ha_DKAqY130_provenance.
- assertion description "[In primary samples, MIR129-2 methylation was absent in AML and CML, but detected in 5% ALL, 45.9% CLL, 49.5% MM at diagnosis, and 59.1% NHL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[In primary samples, MIR129-2 methylation was absent in AML and CML, but detected in 5% ALL, 45.9% CLL, 49.5% MM at diagnosis, and 59.1% NHL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1052732.RACxY-c0jV6Nfig0k38cO44JD_-YNIgcFCBK1WudlrV5g130_assertion description "[In primary samples, MIR129-2 methylation was absent in AML and CML, but detected in 5% ALL, 45.9% CLL, 49.5% MM at diagnosis, and 59.1% NHL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1052732.RACxY-c0jV6Nfig0k38cO44JD_-YNIgcFCBK1WudlrV5g130_provenance.
- NP993310.RAvJKbAkkUS-VzkGZJIjcaiLCm_XIkJuiA8O14Vnx1Moc130_assertion description "[In primary samples, MIR129-2 methylation was absent in AML and CML, but detected in 5% ALL, 45.9% CLL, 49.5% MM at diagnosis, and 59.1% NHL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP993310.RAvJKbAkkUS-VzkGZJIjcaiLCm_XIkJuiA8O14Vnx1Moc130_provenance.
- NP1052724.RALkhnRAAnxzlxNuNbVuW4FZgS9n2NBUawxwVWFHi66qg130_assertion description "[In primary samples, MIR129-2 methylation was absent in AML and CML, but detected in 5% ALL, 45.9% CLL, 49.5% MM at diagnosis, and 59.1% NHL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1052724.RALkhnRAAnxzlxNuNbVuW4FZgS9n2NBUawxwVWFHi66qg130_provenance.